Previous close | 56.26 |
Open | 57.81 |
Bid | 22.59 x 800 |
Ask | 57.77 x 800 |
Day's range | 55.56 - 58.00 |
52-week range | 46.93 - 93.80 |
Volume | |
Avg. volume | 223,183 |
Market cap | 1.392B |
Beta (5Y monthly) | 1.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.37 |
Earnings date | 08 Mar 2022 - 14 Mar 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 93.20 |
Insiders who bought US$4.5m worth of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) stock in the last year have seen...
Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 42.86% and 8.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SANTA BARBARA, Calif., May 09, 2022--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022.